Prime Medicine (NASDAQ:PRME) and Bristol Myers Squibb (NYSE:BMY) will work together on the development of next-generation ex vivo T-cell therapies. The deal calls for Prime Medicine to design ...
Work with experts to understand the cellular and molecular basis of disease and how discoveries can be translated into life-changing applications. Our aim is to inspire you to turn science into ...
Texas Children’s Global HOPE and Baylor College of Medicine Global Health, with support from the Bristol Myers Squibb Foundation, an independent charitable organization, announced the next front in ...
Two-year extension for research and development of alpha-beta T cell medicines for the treatment of cancer and autoimmune diseases CAMBRIDGE, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc., a pioneer in molecular profiling for cancer announced today, an expanded collaboration with Bristol Myers Squibb (NYSE: BMY) to develop ...
Professor Davey Smith's contributions to medical research have marked him as among the most highly recognised scientists ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback